ArticleBMC anesthesiology2026
Anesthesia management for a giant ovarian tumor complicated with heart failure: a case report.
Article in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundLarge tumors can induce severe cardiopulmonary impairment owing to mechanical compression. In extreme cases, chronic compression can precipitate or exacerbate heart failure, a rare but life-threatening complication that significantly increases perioperative risk. Anesthetic management of patients presenting with both massive tumors and consequent heart failure is exceptionally complex. This case report describes the successful multidisciplinary management of a patient with a giant ovarian tumor and secondary heart failure, highlighting the systematic approach to anesthesia. CASE PRESENTATION: A 54-year-old female presented with severe abdominal distension and dyspnea due to a giant ovarian tumor causing chronic heart failure. She underwent tumor resection under general anesthesia. Given the critical physiology of tumor compression and heart failure, specialized anesthetic management was crucial. This included positioning the patient’s reverse Trendelenburg with a left lateral tilt., using anesthesia induction agents (etomidate and remimazolam), implementing a lung-protective ventilation strategy, and performing transesophageal echocardiography (TEE) to guide precise goal-directed fluid therapy. During surgery, 18 L of cystic fluid was drained slowly over 90 min to prevent decompression-induced hypotension, and aggravation of heart failure. The surgery lasted for 5 h. The patient recovered smoothly, was extubated, and discharged three weeks postoperatively.
conclusionsFor patients with giant abdominal tumors and significant physiological compromise, a comprehensive individualized anesthetic plan encompassing postural positioning, drug selection, liquid management, and controlled decompression is essential for maintaining cardiopulmonary stability and ensuring perioperative safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.